Dysregulation of the hepcidin-ferroportin axis underlies diverse pathological conditions, from hereditary hemochromatosis characterized by hepcidin deficiency to anemia of chronic inflammation marked by hepcidin excess (6). This evidence concerns the gene HAMP and anemia (phenotype).